Atlas Trials

Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients

Clinical trial NCT03664843 · UNKNOWN

Trial details

NCT number
NCT03664843
Sponsor
First Hospital of Shijiazhuang City
Status
UNKNOWN
Study type
OBSERVATIONAL
CarcinomaNon-small Cell Lung CancerLung Neoplasm
Start date
2018-11-09
Primary completion
2020-05-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.